Radioiodine uptake in non-lactating mammary glands: Evidence for a causative role of hyperprolactinemia

Thyroid

Volumn 17, Issue 4, 2007, Pages 363-366

  Ronga, Giuseppe ^a   Bruno, Rocco ^b   Puxeddu, Efisio ^c   Calcinaro, Filippo ^c   Montesano, Teresa ^a   Travascio, Laura ^a   Colandrea, Marzia ^a   Durante, Cosimo ^a   Maranghi, Marianna ^a   Filetti, Sebastiano ^a   Russo, Diego ^d  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b Tinchi Pisticci Hospital   (Italy)

^c UNIVERSITY OF PERUGIA   (Italy)

^d UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CABERGOLINE; DELORAZEPAM; DOPAMINE RECEPTOR BLOCKING AGENT; IODINE 131; PAROXETINE; PROLACTIN; RADIOACTIVE IODINE; RISPERIDONE;

ADULT; ANXIETY DISORDER; ARTICLE; BREAST; CASE REPORT; CHRONIC KIDNEY FAILURE; CORRELATION ANALYSIS; DRUG WITHDRAWAL; FEMALE; HUMAN; HUMAN TISSUE; HYPERPROLACTINEMIA; MAMMARY GLAND; POSTMENOPAUSE; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; THYROID CARCINOMA; WHOLE BODY SCINTISCANNING;

BREAST; CARCINOMA, PAPILLARY; FEMALE; HUMANS; HYPERPROLACTINEMIA; IODINE RADIOISOTOPES; KIDNEY FAILURE, CHRONIC; LACTATION; MIDDLE AGED; POSTMENOPAUSE; RISPERIDONE; THYROID NEOPLASMS; THYROIDECTOMY; WHOLE BODY IMAGING;

EID: 34248641412     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2006.0282     Document Type: Article

References (20)

1. Filetti S, Bidart JM, Arturi F, Caillou B, Russo D, Schlumberger M 1999 Sodium/iodide symporter: a key transport system in thyroid cancer cell metabolism. Eur J Endocrinol 141:443-457.
2. Arturi F, Russo D, Schlumberger M, du Villard JA, Caillou B, Vigneri P, Wicker R, Chiefari E, Suarez HG, Filetti S 1998 Iodide symporter gene expression in human thyroid tumors. J Clin Endocrinol Metab 83:2493-2496.
3. Tazebay UH, Wapnir IL, Levy O, Dohan O, Zuckier LS, Zhao QH, Deng HF, Amenta PS, Fineberg S, Pestell RG, Carrasco N 2000 The mammary gland iodide transporter is expressed during lactation and in breast cancer. Nat Med 6:871-888.
4. Dohàn O, de la Vieja A, Paroder V, Riedel C, Artani M, Reed M, Ginter CS, Carrasco N 2003 The sodium/iodide symporter (MS): characterization, regulation, and medical significance. Endocr Rev 24:48-77.
5. Rillema JA, Yu TX 1996 Prolactin stimulation of iodide uptake into mouse mammary gland explants. Am J Physiol 271:E879-E882.
6. Arturi F, Ferretti E, Presta I, Scipioni A, Scarpelli D, Bruno R, Lacroix L, Tosi E, Gulino A, Russo D, Filetti S 2005 Regulation of iodide uptake and sodium/iodide symporter expression in the MCF-7 breast cancer cell line. J Clin Endocrinol Metab 90:2321-2326.
7. Schlumberger M 1998 Papillary and follicular thyroid carcinoma. N Engl J Med 338:297-306.
8. David SR, Taylor CC, Kinon BJ, Breier A 2000 The effects of olanzapine, risperidone and haloperidol in plasma prolactin levels in patients with schizophrenia. Clin Ther 22:1085-1096.
9. Chirito E, Gonda A, Friesen H 1972 Prolactin in renal failure. Clin Res 20:423-428.
10. Holst JP, Burman KD, Atkins F, Umans JG, Jonklaas J 2005 Radioiodine therapy for thyroid cancer and hyperthyroidism in patients with end-stage renal disease on hemodialysis. Thyroid 12:1321-1331.
11. Reynolds C, Montone KT, Powell CM, Tomaszewski JE, Clevenger CV 1997 Expression of prolactin and its receptor in human breast carcinoma. Endocrinology 138:5555-5560.
12. Wapnir IL, van de Rijn M, Nowels K, Amenta PS, Walton K, Montgomery K, Greco RS, Dohan O, Carrasco N 2003 Immunohistochemical profile of the sodium/iodide symporter in thyroid, breast, and other carcinomas using high density tissue microarrays and conventional sections. J Clin Endocrinol Metab 88:1880-1888.
13. Rillema JA, Yu TX, Jhiang SM 2000 Effect of prolactin on sodium iodide symporter expression in mouse mammary gland explants. Am J Physiol Endocrinol Metab 279:E769-E772.
14. - symporter expression in mammary glands. J Clin Endocrinol Metab 85:2936-2943.
15. Bruno R, Giannasio P, Ronga G, Baudin E, Travagli JP, Russo D, Filetti S, Schlumberger M 2004 Sodium iodide symporter expression and radioiodine distribution in extrathyroidal tissues. J Endocrinol Invest 27:1010-1014.
16. Kogai T, Taki K, Brent GA 2006 Enhancement of sodium/ iodide symporter expression in thyroid and breast cancer. Endocr Relat Cancer 13:797-826.
17. Unterholzner S, Willhauck MJ, Cengic N, Schutz M, Goke B, Morris JC, Spitzweg C 2006 Dexamethasone stimulation of retinoic acid-induced sodium iodide symporter expression and cytotoxicity of 131-I in breast cancer cells. J Clin Endocrinol Metab 91:69-78.
18. Dohan O, de la Vieja A, Carrasco N 2006 Hydrocortisone and purinergic signaling stimulate sodium/iodide symporter (NIS)-mediated iodide transport in breast cancer cells. Mol Endocrinol 20:1121-1137.
19. Utama FE, LeBaron MJ, Neilson LM, Sultan AS, Parlow AF, Wagner K-U, Rui H 2006 Human prolactin receptors are insensitive to mouse prolactin: implications for xenotrans-plant modeling of human breast cancer in mice. J Endocrinol 188:589-601.
20. Tworoger SS, Hankinson SE 2006 Prolactin and breast cancer risk. Cancer Lett 243:160-169.